Skip to main content
. Author manuscript; available in PMC: 2024 Jul 11.
Published in final edited form as: Breast Cancer Res Treat. 2023 Apr 24;199(3):565–582. doi: 10.1007/s10549-023-06948-6

Table 3.

Multivariable adjusted linear regression for composite measures and single-rating items associated with breast cancer tumor characteristics among female breast cancer survivors in SEER-CAHPS 2000–2019 completing a CAHPS survey post-diagnosis stratified by race/ethnicity

OUTCOMES PREDICTOR Stratification: race/ethnicity p-int. (predictor x NHB) p-int. (predictor x NHA) p-int. (predictor x Hispanic)
NHW (N = 12,528) NHB (N = 1332) NHA (N = 1020) Hispanic (N = 1001)
N β (SE) p N β (SE) p N β (SE) p N β (SE) p
Getting care quickly (N = 15,881)
Extent of disease: Localized (ref)
Regional 2090 0.35 (0.58) 0.54 245 0.34 (2.05) 0.86 208 − 1.98 (2.09) 0.34 223 2.37 (2.14) 0.26 0.78 0.66 0.32
Distant 264 − 0.61 (1.42) 0.66 34 1.53 (4.88) 0.75 14 1.51 (6.97) 0.82 18 − 6.14 (6.27) 0.32 0.96 0.71 0.27
ER status: ER + (ref)
ER− 1096 − 0.06 (0.74) 0.93 234 − 0.01 (2.20) 0.99 151 − 0.23 (2.33) 0.94 123 1.58 (2.61) 0.61 0.77 0.66 0.32
Missing/Unknown 4284 0.12 (0.72) 0.85 417 − 0.54 (2.57) 0.83 128 − 7.77 (2.90) 0.007 273 − 2.42 (2.76) 0.38 0.95 0.70 0.27
Getting needed care (N = 14,472)
Extent of disease: Localized (ref)
Regional 1950 1.12 (0.50) 0.02 215 2.82 (1.88) 0.13 189 − 1.58 (1.98) 0.42 202 − 0.76 (2.00) 0.70 0.32 0.23 0.67
Distant 254 1.44 (1.22) 0.23 30 − 4.43 (4.47) 0.32 12 − 8.54 (6.71) 0.20 18 − 6.05 (5.66) 0.28 0.10 0.09 0.26
ER status: ER + (ref)
ER− 1021 0.41 (0.65) 0.52 199 4.12 (2.03) 0.04 137 − 1.76 (2.19) 0.42 107 − 1.77 (2.49) 0.47 0.33 0.24 0.68
Missing/Unknown 3907 0.67 (0.63) 0.28 354 − 0.11 (2.36) 0.96 116 − 3.28 (2.72) 0.22 235 − 2.95 (2.66) 0.26 0.11 0.09 0.25
Physician communication (N = 14,314)
Extent of disease: Localized (ref)
Regional 1824 0.19 (0.42) 0.64 231 1.38 (1.29) 0.28 193 − 0.88 (1.43) 0.53 217 0.17 (1.36) 0.89 0.38 0.64 0.60
Distant 240 − 1.78 (1.02) 0.08 27 − 0.99 (3.34) 0.76 12 − 1.78 (4.93) 0.71 19 − 3.19 (3.83) 0.40 0.82 0.86 0.91
ER status: ER + (ref)
ER− 970 0.10 (0.54) 0.85 218 − 0.18 (1.40) 0.89 143 0.31 (1.57) 0.84 111 0.68 (1.72) 0.69 0.40 0.63 0.62
Missing/Unknown 3941 − 0.57 (0.52) 0.27 390 − 1.95 (1.64) 0.23 116 − 2.10 (2.00) 0.29 248 − 1.76 (1.75) 0.31 0.85 0.88 0.92
Getting needed prescription drugs (N = 13,137)
Extent of disease: Localized (ref)
Regional 1651 0.15 (0.50) 0.75 219 1.16 (1.59) 0.46 179 − 0.39 (1.70) 0.81 199 1.22 (1.84) 0.50 0.21 0.91 0.27
Distant 228 − 0.62 (1.18) 0.59 33 − 2.83 (3.63) 0.43 15 − 5.51 (5.03) 0.27 18 − 1.46 (5.15) 0.77 0.54 0.31 0.87
ER status: ER + (ref)
ER− 879 − 0.49 (0.64) 0.43 193 0.33 (1.77) 0.84 139 − 0.86 (1.83) 0.63 108 0.03 (2.29) 0.98 0.24 0.85 0.82
Missing/Unknown 3702 1.24 (0.62) 0.04 378 − 1.97 (2.01) 0.32 120 − 2.00 (2.24) 0.37 265 − 2.75 (2.32) 0.23 0.25 0.63 0.05
Overall care rating (N = 15,957)
Extent of disease: Localized (ref)
Regional 2094 0.34 (0.39) 0.38 248 3.13 (1.47) 0.03 219 − 1.18 (1.41) 0.40 224 2.64 (1.56) 0.09 0.04 0.32 0.23
Distant 271 − 1.26 (0.95) 0.18 31 − 0.60 (3.70) 0.87 14 − 0.27 (4.80) 0.95 19 − 7.01 (4.48) 0.11 0.90 0.81 0.10
ER status: ER + (ref)
ER− 1105 0.02 (0.50) 0.95 228 − 2.05 (1.60) 0.20 157 − 0.01 (1.58) 0.99 125 2.10 (1.90) 0.26 0.05 0.31 0.24
Missing/Unknown 4307 − 0.42 (0.49) 0.39 413 − 0.05 (1.89) 0.97 126 − 4.58 (1.98) 0.02 277 − 1.39 (2.03) 0.49 0.88 0.80 0.10
Health plan rating (N = 16,432)
Extent of disease: Localized (ref)
Regional 2166 0.40 (0.42) 0.34 259 2.29 (1.34) 0.08 226 0.06 (1.38) 0.96 232 − 2.40 (1.39) 0.08 0.06 0.86 0.10
Distant 275 0.47 (1.04) 0.64 33 − 0.26 (3.30) 0.93 15 − 3.02 (4.60) 0.51 21 − 1.26 (3.94) 0.74 0.73 0.30 0.83
ER status: ER + (ref)
ER− 1134 − 0.35 (0.55) 0.52 241 − 1.13 (1.45) 0.43 157 0.87 (1.56) 0.57 129 1.37 (1.72) 0.42 0.06 0.86 0.11
Missing/Unknown 4433 0.50 (0.53) 0.34 421 − 0.98 (1.70) 0.56 131 − 4.31 (1.90) 0.02 290 0.02 (1.78) 0.98 0.73 0.30 0.83
Physician rating (N = 14,354)
Extent of disease: Localized (ref)
Regional 1837 0.38 (0.38) 0.31 232 3.47 (1.19) 0.004 191 − 0.91 (1.24) 0.46 212 − 0.61 (1.39) 0.65 0.02 0.41 0.19
Distant 236 − 2.13 (0.93) 0.02 24 0.57 (3.27) 0.86 12 3.01 (4.24) 0.47 18 − 0.35 (3.99) 0.92 0.47 0.39 0.58
ER status: ER + (ref)
ER− 977 − 0.41 (0.49) 0.40 219 0.14 (1.30) 0.91 141 − 0.29 (1.36) 0.83 109 0.38 (1.76) 0.82 0.67 0.92 0.91
Missing/Unknown 3956 − 0.33 (0.47) 0.47 379 1.24 (1.53) 0.41 115 − 3.12 (1.72) 0.07 246 − 1.90 (1.78) 0.28 0.19 0.002 0.17

CAHPS Consumer assessment of healthcare providers and systems, ER estrogen receptor, int. interaction, NHA non-Hispanic Asian or Pacific Islander, NHB non-Hispanic Black or African American, NHW non-Hispanic white, SE standard error, SEER Surveillance, epidemiology, and end results program

Missing values: Getting care quickly composite (2963); Getting needed care composite (4379); Physician communication composite (4548); Getting needed prescription drugs composite (5722); Overall care rating (2890); Health plan rating (2402); Physician rating (4509); race/ethnicity (194)

Case-mix adjustments for years 1999–2019: Age at CAHPS survey (65–69, 70–74, 75–79, 80–84, ≥ 85); Education (< high school, high school graduate/GED/some college, college graduate); General health status (excellent/very good, good, fair/poor); Received help responding (no, yes); Proxy answered questions for respondent (no, yes)

Additional adjusted covariates: age at diagnosis (continuous); Mental health status (excellent/very good; good; fair/poor; missing); years from diagnosis to CAHPS survey (continuous); Centers for Medicare & Medicaid Services (CMS) multimorbidity (continuous); CAHPS survey year (continuous); area-level poverty (0– < 20% poverty; 20–100% poverty; unknown/missing); Medicare plan type (other [prescription drug plan {PDP} or Medicare Advantage {MA}], fee-for-service Medicare)

Borderline cases for ER status (13) were excluded

Predictors and stratifications are mutually adjusted

Bold font indicates statistically significant with corresponding p < .05